Cover Image
市場調查報告書

中國的即時臨床檢測(POCT)市場

POCT Market in China 2014-2018

出版商 TechNavio (Infiniti Research Ltd.) 商品編碼 312482
出版日期 內容資訊 英文 76 Pages
訂單完成後即時交付
價格
Back to Top
中國的即時臨床檢測(POCT)市場 POCT Market in China 2014-2018
出版日期: 2014年09月10日 內容資訊: 英文 76 Pages
簡介

即時臨床檢測(POCT),隨著糖尿病、心臟疾病、肥胖症的文明病的增加而開始普及。POCT在患者的QOL(Ouality of 在Life:生活品質)的提高上,發揮很大的作用。中國的POCT市場,預計從2013年到2018年,以20.69%的年複合成長率擴大。

本報告提供中國的即時臨床檢測(POCT)市場現況與未來預測、各應用領域、各技術趨勢、市場發展要素與課題、主要企業分析等。

第1章 摘要整理

第2章 簡稱清單

第3章 調查範圍

  • 市場概要
  • 主要的產品

第4章 市場調查手法

  • 市場調查流程
  • 調查手法

第5章 簡介

第6章 市場形勢

  • 市場概要
  • 市場規模與預測
  • 波特的五力分析

第7章 各應用領域的市場區隔

  • 血糖值檢驗
  • 膽固醇檢驗
  • 傳染病檢查
  • 血中氣體檢驗
  • 心臟生物標記檢驗
  • 妊娠檢驗

第8章 各技術的市場區隔

  • 電化學生物感應器
  • 光學生物感應器
  • 壓電生物感應器

第9章 購買標準

第10章 市場成長因素

第11章 成長因素與其影響

第12章 市場課題

第13章 成長因素與課題的影響

第14章 市場趨勢

第15章 趨勢與其影響

第16章 業者情勢

  • 競爭模式
    • 主要消息
  • 市場佔有率分析
  • 其他卓越供應商
  • Abbott Laboratories
  • Bayer HealthCare
  • LifeScan
  • F. Hoffmann La Roche
目錄
Product Code: IRTNTR4131

About POCT

POCT, also called near-patient testing, is performed outside a clinical laboratory. It helps in making fast clinical decisions, and hence in administrating appropriate treatments and medication. POCT is gaining popularity due to the increasing incidence and prevalence of lifestyle diseases such as diabetes, heart disease, and obesity. It is generally cost-effective and user-friendly. POCT devices are standardized to minimize errors during the diagnosis of patients. POCT plays a major role in improving patients' quality of life.

TechNavio's analysts forecast the POCT market in China to grow at a CAGR of 20.69 percent over the period 2013-2018.

Covered in this Report

This report covers the present scenario and the growth prospects of the POCT market in China for the period 2014-2018. To calculate the market size, the report considers the revenue generated through the following applications of POCT:

  • Blood glucose testing
  • Cholesterol testing
  • Infectious disease testing
  • Blood gas testing
  • Cardiac biomarkers testing
  • Pregnancy testing
  • Others (such as cancer biomarker, electrolyte analyzers, blood coagulation testing, tumor marker, and urinalysis testing)

TechNavio's report, the POCT Market in China 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers China; it also covers the landscape of the POCT market in China and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Key Region

  • China

Key Vendors

  • Abbott Laboratories
  • Bayer HealthCare
  • F. Hoffmann-La Roche
  • LifeScan

Other Prominent Vendors

  • Bioptik Technology
  • Chongqing Haray International Business
  • Fudakang Ind'l
  • Guangzhou Maya Medical Equipment
  • Jiangxi Zhongchenda Industrial Investment
  • Nantong Voyage International Trade
  • Shenzhen Fitconn Technology
  • Shiny Health Import & Export
  • Sunrising Enterprise
  • Wuhan HNC Technology
  • Yuan Yu Bio-Tech

Market Driver

  • Technological Innovations

For a full, detailed list, view our report

Market Challenge

  • Advances in Technology

For a full, detailed list, view our report

Market Trend

  • Expanding Economy of China

For a full, detailed list, view our report

Key Questions Answered in this Report

  • What will the market size be in 2018 and what will the growth rate be
  • What are the key market trends
  • What is driving this market
  • What are the challenges to market growth
  • Who are the key vendors in this market space
  • What are the market opportunities and threats faced by the key vendors
  • What are the strengths and weaknesses of the key vendors

Table of Contents

01. Executive Summary

02. List of Abbreviations

03. Scope of the Report

  • 03.1. Market Overview
  • 03.2. Product Offerings

04. Market Research Methodology

  • 04.1. Market Research Process
  • 04.2. Research Methodology

05. Introduction

06. Market Landscape

  • 06.1. Market Overview
  • 06.2. Market Size and Forecast
  • 06.3. Five Forces Analysis

07. Market Segmentation by Application

  • 07.1. Blood Glucose Testing Market in China
    • 07.1.1. Market Size and Forecast
  • 07.2. Cholesterol Testing Market in China
    • 07.2.1. Market Size and Forecast
  • 07.3. Infectious Disease Testing Market in China
    • 07.3.1. Market Size and Forecast
  • 07.4. Blood Gas Testing Market in China
    • 07.4.1. Market Size and Forecast
  • 07.5. Cardiac Biomarkers Testing Market in China
    • 07.5.1. Market Size and Forecast
  • 07.6. Pregnancy Testing Market in China
    • 07.6.1. Market Size and Forecast

08. Market Segmentation by Technology

  • 08.1. Electrochemical Biosensors
  • 08.2. Optical Biosensors
  • 08.3. Piezoelectric Biosensors

09. Buying Criteria

10. Market Growth Drivers

11. Drivers and their Impact

12. Market Challenges

13. Impact of Drivers and Challenges

14. Market Trends

15. Trends and their Impact

16. Vendor Landscape

  • 16.1. Competitive Scenario
    • 16.1.1. Key News
  • 16.2. Market Share Analysis 2013
  • 16.3. Other Prominent Vendors
  • 16.4. Abbott Laboratories
    • 16.4.1. Key Facts
    • 16.4.2. Business Overview
    • 16.4.3. Business Segmentation by Revenue 2012
    • 16.4.4. Business Segmentation by Revenue 2011 and 2012
    • 16.4.5. Geographical Segmentation by Revenue 2012
    • 16.4.6. Business Strategy
    • 16.4.7. Key Information
    • 16.4.8. SWOT Analysis
    • 16.4.9. Strengths
    • 16.4.10. Weakness
    • 16.4.11. Opportunities
    • 16.4.12. Threats
  • 16.5. Bayer HealthCare
    • 16.5.1. Key Facts
    • 16.5.2. Business Overview
    • 16.5.3. Business Segmentation by Revenue 2013
    • 16.5.4. Business Segmentation by Revenue 2012 and 2013
    • 16.5.5. Geographical Segmentation by Revenue 2013
    • 16.5.6. Business Strategy
    • 16.5.7. Recent Developments
    • 16.5.8. SWOT Analysis
    • 16.5.9. Strengths
    • 16.5.10. Weaknesses
    • 16.5.11. Opportunities
    • 16.5.12. Threats
  • 16.6. LifeScan
    • 16.6.1. Key Facts
    • 16.6.2. Business Overview
    • 16.6.3. Product Segmentation
    • 16.6.4. Geographical Segmentation by Revenue 2013
    • 16.6.5. Business Strategy
    • 16.6.6. Recent Developments
    • 16.6.7. SWOT Analysis
    • 16.6.8. Strengths
    • 16.6.9. Weaknesses
    • 16.6.10. Opportunities
    • 16.6.11. Threats
  • 16.7. F. Hoffmann La Roche
    • 16.7.1. Key Facts
    • 16.7.2. Business Overview
    • 16.7.3. Business Segmentation by Revenue 2013
    • 16.7.4. Business Segmentation by Revenue 2012 and 2013
    • 16.7.5. Sales by Geography 2013
    • 16.7.6. Business Strategy
    • 16.7.7. Recent Developments
    • 16.7.8. SWOT Analysis
    • 16.7.9. Strengths
    • 16.7.10. Weaknesses
    • 16.7.11. Opportunities
    • 16.7.12. Threats

List of Exhibits:

  • Exhibit 1: Market Research Methodology
  • Exhibit 2: POCT market in China 2013-2018 (US$ million)
  • Exhibit 3: POCT Market in China Segmentation by Application
  • Exhibit 4: POCT Market in China Segmentation by Application 2013
  • Exhibit 5: Blood Glucose Testing Market in China 2013-2018 (US$ million)
  • Exhibit 6: Cholesterol Testing Market in China 2013-2018 (US$ million)
  • Exhibit 7: Infectious Disease Testing Market in China 2013-2018 (US$ million)
  • Exhibit 8: Blood Gas Testing Market in China 2013-2018 (US$ million)
  • Exhibit 9: Cardiac Biomarkers Testing Market in China 2013-2018 (US$ million)
  • Exhibit 10: Pregnancy Testing Market in China 2013-2018 (US$ million)
  • Exhibit 11: POCT market in China Segmentation by Application 2013-2018
  • Exhibit 12: POCT Market Segmentation by Technology in China
  • Exhibit 13: Abbott Laboratories: Business Segmentation by Revenue 2012
  • Exhibit 14: Abbott Laboratories: Business Segmentation by Revenue 2011 and 2012 (US$ million)
  • Exhibit 15: Abbott Laboratories: Geographical Segmentation by Revenue 2012
  • Exhibit 16: Bayer Healthcare: Business Segmentation by Revenue 2013
  • Exhibit 17: Bayer Healthcare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
  • Exhibit 18: Bayer Healthcare: Geographical Segmentation by Revenue 2013
  • Exhibit 19: LifeScan: Product Segmentation 2013
  • Exhibit 20: LifeScan: Geographical Segmentation by Revenue 2013
  • Exhibit 21: F. Hoffmann-La Roche: Business Segmentation by Revenue 2013
  • Exhibit 22: F. Hoffmann-La Roche: Business Segmentation by Revenue 2012 and 2013
  • Exhibit 23: F. Hoffmann-La Roche: Sales of Pharmaceuticals Division by Geography 2013
  • Exhibit 24: F. Hoffmann-La Roche: Sales of Diagnostics Division by Geography 2013
Back to Top